These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32232702)

  • 1. Review of early endoscopic findings in patients with local recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yamamoto Y; Kadota T; Yoda Y; Hori K; Hatogai K; Kojima T; Fujii S; Akimoto T; Yano T
    Esophagus; 2020 Oct; 17(4):433-439. PubMed ID: 32232702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.
    Sato D; Motegi A; Kadota T; Kojima T; Bando H; Shinmura K; Hori K; Yoda Y; Oono Y; Zenda S; Ikematsu H; Akimoto T; Yano T
    Esophagus; 2020 Jul; 17(3):305-311. PubMed ID: 31965362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer.
    Hatogai K; Yano T; Kojima T; Onozawa M; Fujii S; Daiko H; Yoda Y; Hombu T; Doi T; Kaneko K; Ohtsu A
    Radiat Oncol; 2016 Feb; 11():31. PubMed ID: 26922374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
    Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
    Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Tu CH; Muto M; Horimatsu T; Taku K; Yano T; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Dis Esophagus; 2011 May; 24(4):274-8. PubMed ID: 21087347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
    Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
    Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Kimura H; Yoshida M; Yabuuchi Y; Kakushima N; Yamamoto Y; Kawata N; Takizawa K; Kishida Y; Imai K; Ito S; Hotta K; Ishiwatari H; Matsubayashi H; Ono H
    Jpn J Clin Oncol; 2021 Jul; 51(7):1036-1043. PubMed ID: 33758950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of patients with recurrent squamous cell carcinoma of the esophagus undergoing salvage endoscopic resection after definitive chemoradiotherapy.
    Ego M; Abe S; Nakatani Y; Nonaka S; Suzuki H; Yoshinaga S; Oda I; Kato K; Honma Y; Itami J; Daiko H; Saito Y; Boku N
    Surg Endosc; 2021 Apr; 35(4):1766-1776. PubMed ID: 32356109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy.
    Koizumi S; Jin M; Matsuhashi T; Tawaraya S; Watanabe N; Sawaguchi M; Kanazawa N; Yamada Y; Onochi K; Kimura Y; Ohba R; Kataoka J; Hatakeyma N; Mashima H; Ohnishi H
    Gastrointest Endosc; 2014 Feb; 79(2):348-53. PubMed ID: 24125510
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage Endoscopic Argon Plasma Coagulation After Chemoradiotherapy for Inoperable Esophageal Cancer.
    Matsutani T; Nomura T; Hagiwara N; Matsuda A; Uchida E
    Surg Laparosc Endosc Percutan Tech; 2017 Oct; 27(5):384-390. PubMed ID: 28727635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
    Ikawa T; Ishihara R; Matsueda K; Konishi K; Yamamoto S; Morimoto M; Kanayama N; Teshima T
    BMC Cancer; 2022 Mar; 22(1):301. PubMed ID: 35313853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage endoscopic resection for cT1N0M0 local recurrence after chemoradiotherapy for esophageal squamous cell carcinoma: endoscopic submucosal dissection versus endoscopic mucosal resection.
    Nakajo K; Yoda Y; Yamashita H; Takashima K; Murano T; Kadota T; Shinmura K; Ikematsu H; Akimoto T; Yano T
    Jpn J Clin Oncol; 2022 Sep; 52(9):982-991. PubMed ID: 35675653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
    Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
    Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
    Haneda R; Booka E; Ishii K; Kikuchi H; Hiramatsu Y; Kamiya K; Ogawa H; Yasui H; Takeuchi H; Tsubosa Y
    World J Surg; 2021 Jun; 45(6):1835-1844. PubMed ID: 33620541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
    Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage treatment for superficial local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Nagai Y; Yoshida N; Baba H
    Dig Endosc; 2020 Jan; 32(1):146. PubMed ID: 31535391
    [No Abstract]   [Full Text] [Related]  

  • 19. Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.
    Sudo K; Kato K; Kuwabara H; Sasaki Y; Takahashi N; Shoji H; Iwasa S; Honma Y; Okita NT; Takashima A; Hamaguchi T; Yamada Y; Ito Y; Itami J; Fukuda T; Tobinai K; Boku N
    Oncology; 2018; 94(1):47-54. PubMed ID: 29080886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy.
    Honing J; Koch AD; Siersema PD; Spaander M
    Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101885. PubMed ID: 38522883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.